Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.
Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.
复制标题
DOI:
10.2337/dc11-1108
复制
发表时间:
2011-10
期刊:
影响因子:
16.2
通讯作者:
Boulton AJ
中科院分区:
文献类型:
--
作者:
Abbott CA;Malik RA;van Ross ER;Kulkarni J;Boulton AJ
To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.
登录
查看更多内容
影响因子:
3.6
作者:
Ziegler, Dan;Rathmann, Wolfgang;Mielck, Andreas
通讯作者:
Mielck, Andreas
影响因子:
2.3
作者:
Halawa, Mohamed Reda;Karawagh, Abdullah;Hegazy, Ahmed
通讯作者:
Hegazy, Ahmed
影响因子:
8.2
作者:
Tesfaye, S;Stevens, LK;Ward, JD
通讯作者:
Ward, JD
影响因子:
8.2
作者:
YOUNG, MJ;BOULTON, AJM;SONKSEN, PH
通讯作者:
SONKSEN, PH
影响因子:
8.2
作者:
Cabezas-Cerrato, J
通讯作者:
Cabezas-Cerrato, J